OptimizeRx secures $35M credit facility with Fifth Third, refinances debt and enables buybacks

Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read

Key Changes

• high

  OptimizeRx closed a $35M credit facility with Fifth Third Bank ($10M revolving line, $25M term loan) with 5-year maturity through May 2031. Facility includes accordion feature allowing up to $25M additional capacity.

  Item 1.01 verify on EDGAR →
• high

  Company used term loan proceeds to fully repay and terminate October 2023 debt facility with Blue Torch Finance. Remaining funds allocated for stock repurchases (subject to credit agreement limits), transaction costs, and working capital.

  Item 1.01 verify on EDGAR →
• high

  New facility requires quarterly financial covenant compliance: minimum 1.20x fixed charge coverage ratio and maximum 2.75x total net leverage ratio. Violation could trigger default and accelerate repayment obligations.

  Item 1.01 verify on EDGAR →